SCHEMBL12470822

SCHEMBL12470822

Oc1ccc(C2NCCS2)cc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
TDP1 Q9NUW8 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
ALDH1A1 P00352 2/20 0.51
QDPR P09417 3/20 0.47
PTPN1 P18031 1/20 0.40
ALOX5 P09917 1/20 0.40
ERN1 O75460 1/20 0.39
MAPK1 P28482 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
THPO P40225 1/20 0.38
KDM4E B2RXH2 2/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
PMP22 Q01453 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30683720 1.00 MAPT (0.56) MAPTTDP1SMN1; SMN2ALDH1A1QDPR
SCHEMBL2082412 0.81 TSHR (0.57) MAPTTDP1SMN1; SMN2ALDH1A1QDPR
SCHEMBL12470967 0.81 ERN1 (0.52) MAPTTDP1SMN1; SMN2ALDH1A1ERN1
SCHEMBL12470469 0.78 GAA (0.51) MAPTTDP1SMN1; SMN2ALDH1A1ERN1
SCHEMBL11174447 0.77 MAPT (0.50) MAPTTDP1SMN1; SMN2ALDH1A1ERN1
SCHEMBL30683721 0.77 MAPT (0.50) MAPTTDP1SMN1; SMN2ALDH1A1ERN1
SCHEMBL29155410 0.76 MAPT (0.52) MAPTTDP1SMN1; SMN2ALDH1A1ERN1
SCHEMBL2082827 0.72 MAPT (1.00) MAPTTDP1SMN1; SMN2ALDH1A1ERN1
SCHEMBL10896316 0.72 MAPT (1.00) MAPTTDP1SMN1; SMN2ALDH1A1ERN1
SCHEMBL11401198 0.71 ERN1 (0.43) MAPTTDP1SMN1; SMN2ALDH1A1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117209445-A Thiazolidine phenol derivative, preparation method and application thereof and whitening cream 广州番禺职业技术学院 2023-12-12 CN claimed
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NAT UNIV IND COOP FOUND (KR) 2015-12-24 US claimed
WO-2012108689-A2 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR 부산대학교 산학협력단 (KR) 2012-08-16 WO claimed
CN-117209445-A Thiazolidine phenol derivative, preparation method and application thereof and whitening cream 广州番禺职业技术学院 2023-12-12 CN disclosed
CN-117209445-A Thiazolidine phenol derivative, preparation method and application thereof and whitening cream 广州番禺职业技术学院 2023-12-12 CN disclosed
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NAT UNIV IND COOP FOUND (KR) 2015-12-24 US disclosed
US-9155690-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2015-10-13 US disclosed
US-8889881-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor Pusan National University Industry —University Cooperation Foundation (KR) 2014-11-18 US disclosed
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR Pusan National University Indusrtyuniversity (KR) 2014-02-06 US disclosed
WO-2012108689-A2 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR 부산대학교 산학협력단 (KR) 2012-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PPARG, PPARA, TYR MAPT 1956/4885TDP1 1176/4885SMN1; SMN2 3671/4885
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR PPARG, PPARA, PPARD MAPT 2700/4885TDP1 1138/4885SMN1; SMN2 4087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.